Emanuel F. Petricoin

MedicineChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Table from Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma

10.1158/1535-7163.22522299.v1

Top 100%

0DataRank

Top 100%0 citations

Antje Schaefer, Craig M. Goodwin, Victoria V. Nguyen, Frances L. Massey, Mariaelena Pierobon +10 more

Papers

Driven by 23 papers — median percentile 0. Top paper: “RHOAL57Vdrives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling”.

RHOAL57Vdrives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling

Science Signaling(2023)10.1126/scisignal.adg5289

N/A

0.575DataRank · unranked

9 citations

Richard G. Hodge, Haisheng Zhang, G. Aaron Hobbs, Julien Dilly, Minh V. Huynh +15 more

Cancer metabolism and mass spectrometry-based proteomics

Cancer Letters(2015)10.1016/j.canlet.2013.11.003

N/A

0.538DataRank · unranked

35 citations

Lance A. Liotta, Emanuel F. Petricoin, Weidong Zhou

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2256

N/A

0.457DataRank · unranked

20 citations

Christina Yau, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien +44 more

The NF-κB/leukemia inhibitory factor/STAT3 signaling pathway in antibody-mediated suppression of Sindbis virus replication in neurons

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2016691117

N/A

0.434DataRank · unranked

17 citations

Kimberly L. W. Schultz, Valerie Calvert, Emanuel F. Petricoin, Diane E. Griffin, Jane Yeh

Seropositivity of COVID-19 among asymptomatic healthcare workers: A multi-site prospective cohort study from Northern Virginia, United States

The Lancet Regional Health - Americas(2021)10.1016/j.lana.2021.100030

N/A

0.406DataRank · unranked

14 citations

Siqi Wei, Scott A. Bruce, Amanda Haymond, Emanuel F. Petricoin, Lance A. Liotta +8 more

HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic Cancer

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0355

N/A

0.165DataRank · unranked

2 citations

Yifei Guo, Alexandra Q. Bartlett, Kevin Hawthorne, Matthew Reyer, Margaret Haerr +10 more

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

Nature Cancer(2022)10.1038/s43018-022-00394-x

N/A

0DataRank · unranked

42 citations

Justine C. Rutter, Abigail Xie, Shane T. Killarney, Camille Vaganay, Chaı̈ma Benaksas +28 more

Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS -Mutant Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.17.508384

N/A

0DataRank · unranked

1 citations

Colin A. Martz, Andrew M. Waters, Alejandro Barrera, Justine C. Rutter, Christian Cerda-Smith +14 more

Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers

Research Square(2023)10.21203/rs.3.rs-3511242/v1

N/A

0DataRank · unranked

0 citations

Daniel P. Nussbaum, Colin A. Martz, Andrew M. Waters, Alejandro Barrera, Justine C. Rutter +13 more

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

UNC Libraries(2024)10.17615/s0p7-tg86

N/A

0DataRank · unranked

12 citations

Jennifer E. Klomp, Bjoern Papke, Craig M. Goodwin, Andrew P. Beelen, Clint A. Stalnecker +19 more

Inhibition of UV-Induced Stress Signaling and Inflammatory Responses in SKH-1 Mouse Skin by Topical Small-Molecule PD-L1 Blockade

JID Innovations(2024)10.1016/j.xjidi.2023.100255

N/A

0DataRank · unranked

8 citations

Prajakta Vaishampayan, Jana Jandová, Yuchen Ai, Viktoria Kirschnerova, Tianshun Zhang +9 more

Multiomic-Based Molecular Landscape of FaDu Xenograft Tumors in Mice after a Combinatorial Treatment with Radiation and an HSP90 Inhibitor Identifies Adaptation-Induced Targets of Resistance and Therapeutic Intervention

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0796

N/A

0DataRank · unranked

4 citations

Uma Shankavaram, Molykutty J. Aryankalayil, Sunita Chopra, Sarwat Naz, Anastasia L. Sowers +7 more

Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cells

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.14.585115

N/A

0DataRank · unranked

1 citations

Oluwademilade Nuga, Indrani Datta, Kimberly Bergman, Thaís S. Sabedot, Katherine Gurdziel +14 more

Acquired resistance to CDK4/6 inhibition is associated with dysregulation of multiple pathways including cyclin D-CDK4/6-RB, EGFR/HER, AKT/mTOR and IFN signaling

Research Square(2024)10.21203/rs.3.rs-3782509/v1

N/A

0DataRank · unranked

0 citations

Lauren Bathurst, Linda M. Liao, Megan Hopkins, Cheryl Crozier, Quang M. Trinh +4 more

Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit

Molecular & Cellular Proteomics(2024)10.1016/j.mcpro.2024.100870

N/A

0DataRank · unranked

0 citations

Midori Iida, Takeshi Iwaya, Akiko Yashima‐Abo, Yuka Koizumi, Akari Endo +16 more

Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment

PLoS ONE(2025)10.1371/journal.pone.0315171

N/A

0DataRank · unranked

4 citations

Oluwademilade Nuga, Indrani Datta, Kimberly Bergman, Thaís S. Sabedot, Katherine Gurdziel +14 more

PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-19-0592

N/A

0DataRank · unranked

18 citations

Christine E. Lehman, Adam Spencer, Rolando E. Mendez, Abel P. David, Linnea E. Taniguchi +5 more

Supplementary Table from Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma

10.1158/1535-7163.22522299.v1

Top 100%

0DataRank

Top 100%0 citations

Antje Schaefer, Craig M. Goodwin, Victoria V. Nguyen, Frances L. Massey, Mariaelena Pierobon +10 more

PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0160

N/A

0DataRank · unranked

9 citations

Neha Singh, Libia A. Leuvano, Valerie Calvert, Emanuel F. Petricoin, David T. Teachey +5 more

Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.22.050385

N/A

0DataRank · unranked

14 citations

Santosh Gupta, Jared Eng, Gabor Kemeny, Bhairavy Puviindran, Wen‐Chi Foo +18 more

Exosomes originating from infection with the cytoplasmic single-stranded RNA virus Rift Valley fever virus (RVFV) protect recipient cells by inducing RIG-I mediated IFN-B response that leads to activation of autophagy

Cell & Bioscience(2021)10.1186/s13578-021-00732-z

N/A

0DataRank · unranked

21 citations

Adeyemi A. Olanrewaju, Samson Omole, Heather E. Hobbs, Noor A. Ahsan, Graham Matulis +10 more

Regulation of Chemosensitivity in Human Medulloblastoma Cells by p53 and the PI3 Kinase Signaling Pathway

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0277

N/A

0DataRank · unranked

17 citations

Varsha Harish, Sophie Coste, Erika M. Parasido, Muhammad Umer Choudhry, Lawrence F. Kromer +11 more

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-0391

N/A

0DataRank · unranked

163 citations

Andrew M. Waters, Jennifer E. Klomp, Sehrish Javaid, Kirsten L. Bryant, Clint A. Stalnecker +19 more

Emanuel F. Petricoin

Indexed papers

Top data-sharing exemplar

Papers